HIV and the mucosa: No safe haven

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Since its discovery in 1983, Human Immunodeficiency Virus-1 (HIV) infection has resulted in the death of several million people worldwide. Control of the spread of HIV infections is one of the major concerns of the scientific community today. This retrovirus houses a genome encoding three viral structural proteins: group-specific antigen, polymerase and envelope. The envelope gp120 binds to cell surface receptors on susceptible target cells in the host. Although HIV is known to infect various cell types, cells expressing the CD4 receptor support high levels of viral replication in vivo. Gastrointestinal complications are commonly seen in patients with HIV-1 infections progressing to AIDS. Recent studies have shown that HIV causes massive disruption of the Gut Associated Lymphoid Tissue (GALT) very early in infection. Intestinal dysfunction is often not resolved despite the success of HAART in improving the clinical status of these patients. GALT supports robust viral replication in mucosal memory CD4+ T cells during primary HIV infection, leading to a severe depletion of the CD4+ T cells which persists through all stages of HIV infection in the absence of therapeutic interventions. Functional genomic analysis of host responses to HIV shows that molecular processes regulating inflammation and immune activation are dominantly expressed in GALT of therapy-nave HIV-1 infected patients with a progressive clinical course. Heterosexual transmission is the primary mode for the spread of HIV infection and the virus gains entry through mucosal surfaces and infects susceptible target cells. Since a majority of new infections are acquired through the mucosal route, induction of mucosal immunity is an important factor in vaccine design.

Original languageEnglish (US)
Title of host publicationImmunity Against Mucosal Pathogens
PublisherSpringer Netherlands
Pages459-481
Number of pages23
ISBN (Print)9781402084126, 9781402084119
DOIs
StatePublished - 2008

Fingerprint

HIV-1
Mucous Membrane
Virus Diseases
Lymphoid Tissue
Infection
Viral Structural Proteins
T-Lymphocytes
Virus Internalization
Mucosal Immunity
CD4 Antigens
Heterosexuality
Highly Active Antiretroviral Therapy
Cell Surface Receptors
Retroviridae
Cell- and Tissue-Based Therapy
Acquired Immunodeficiency Syndrome
Vaccines
Genome
Inflammation
Antigens

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)

Cite this

Dandekar, S., Sankaran-Walters, S., & Glavan, T. (2008). HIV and the mucosa: No safe haven. In Immunity Against Mucosal Pathogens (pp. 459-481). Springer Netherlands. https://doi.org/10.1007/978-1-4020-8412-6_17

HIV and the mucosa : No safe haven. / Dandekar, Satya; Sankaran-Walters, Sumathi; Glavan, Tiffany.

Immunity Against Mucosal Pathogens. Springer Netherlands, 2008. p. 459-481.

Research output: Chapter in Book/Report/Conference proceedingChapter

Dandekar, S, Sankaran-Walters, S & Glavan, T 2008, HIV and the mucosa: No safe haven. in Immunity Against Mucosal Pathogens. Springer Netherlands, pp. 459-481. https://doi.org/10.1007/978-1-4020-8412-6_17
Dandekar S, Sankaran-Walters S, Glavan T. HIV and the mucosa: No safe haven. In Immunity Against Mucosal Pathogens. Springer Netherlands. 2008. p. 459-481 https://doi.org/10.1007/978-1-4020-8412-6_17
Dandekar, Satya ; Sankaran-Walters, Sumathi ; Glavan, Tiffany. / HIV and the mucosa : No safe haven. Immunity Against Mucosal Pathogens. Springer Netherlands, 2008. pp. 459-481
@inbook{44f0bb8b7106471c8ba4e5836784e0ac,
title = "HIV and the mucosa: No safe haven",
abstract = "Since its discovery in 1983, Human Immunodeficiency Virus-1 (HIV) infection has resulted in the death of several million people worldwide. Control of the spread of HIV infections is one of the major concerns of the scientific community today. This retrovirus houses a genome encoding three viral structural proteins: group-specific antigen, polymerase and envelope. The envelope gp120 binds to cell surface receptors on susceptible target cells in the host. Although HIV is known to infect various cell types, cells expressing the CD4 receptor support high levels of viral replication in vivo. Gastrointestinal complications are commonly seen in patients with HIV-1 infections progressing to AIDS. Recent studies have shown that HIV causes massive disruption of the Gut Associated Lymphoid Tissue (GALT) very early in infection. Intestinal dysfunction is often not resolved despite the success of HAART in improving the clinical status of these patients. GALT supports robust viral replication in mucosal memory CD4+ T cells during primary HIV infection, leading to a severe depletion of the CD4+ T cells which persists through all stages of HIV infection in the absence of therapeutic interventions. Functional genomic analysis of host responses to HIV shows that molecular processes regulating inflammation and immune activation are dominantly expressed in GALT of therapy-nave HIV-1 infected patients with a progressive clinical course. Heterosexual transmission is the primary mode for the spread of HIV infection and the virus gains entry through mucosal surfaces and infects susceptible target cells. Since a majority of new infections are acquired through the mucosal route, induction of mucosal immunity is an important factor in vaccine design.",
author = "Satya Dandekar and Sumathi Sankaran-Walters and Tiffany Glavan",
year = "2008",
doi = "10.1007/978-1-4020-8412-6_17",
language = "English (US)",
isbn = "9781402084126",
pages = "459--481",
booktitle = "Immunity Against Mucosal Pathogens",
publisher = "Springer Netherlands",

}

TY - CHAP

T1 - HIV and the mucosa

T2 - No safe haven

AU - Dandekar, Satya

AU - Sankaran-Walters, Sumathi

AU - Glavan, Tiffany

PY - 2008

Y1 - 2008

N2 - Since its discovery in 1983, Human Immunodeficiency Virus-1 (HIV) infection has resulted in the death of several million people worldwide. Control of the spread of HIV infections is one of the major concerns of the scientific community today. This retrovirus houses a genome encoding three viral structural proteins: group-specific antigen, polymerase and envelope. The envelope gp120 binds to cell surface receptors on susceptible target cells in the host. Although HIV is known to infect various cell types, cells expressing the CD4 receptor support high levels of viral replication in vivo. Gastrointestinal complications are commonly seen in patients with HIV-1 infections progressing to AIDS. Recent studies have shown that HIV causes massive disruption of the Gut Associated Lymphoid Tissue (GALT) very early in infection. Intestinal dysfunction is often not resolved despite the success of HAART in improving the clinical status of these patients. GALT supports robust viral replication in mucosal memory CD4+ T cells during primary HIV infection, leading to a severe depletion of the CD4+ T cells which persists through all stages of HIV infection in the absence of therapeutic interventions. Functional genomic analysis of host responses to HIV shows that molecular processes regulating inflammation and immune activation are dominantly expressed in GALT of therapy-nave HIV-1 infected patients with a progressive clinical course. Heterosexual transmission is the primary mode for the spread of HIV infection and the virus gains entry through mucosal surfaces and infects susceptible target cells. Since a majority of new infections are acquired through the mucosal route, induction of mucosal immunity is an important factor in vaccine design.

AB - Since its discovery in 1983, Human Immunodeficiency Virus-1 (HIV) infection has resulted in the death of several million people worldwide. Control of the spread of HIV infections is one of the major concerns of the scientific community today. This retrovirus houses a genome encoding three viral structural proteins: group-specific antigen, polymerase and envelope. The envelope gp120 binds to cell surface receptors on susceptible target cells in the host. Although HIV is known to infect various cell types, cells expressing the CD4 receptor support high levels of viral replication in vivo. Gastrointestinal complications are commonly seen in patients with HIV-1 infections progressing to AIDS. Recent studies have shown that HIV causes massive disruption of the Gut Associated Lymphoid Tissue (GALT) very early in infection. Intestinal dysfunction is often not resolved despite the success of HAART in improving the clinical status of these patients. GALT supports robust viral replication in mucosal memory CD4+ T cells during primary HIV infection, leading to a severe depletion of the CD4+ T cells which persists through all stages of HIV infection in the absence of therapeutic interventions. Functional genomic analysis of host responses to HIV shows that molecular processes regulating inflammation and immune activation are dominantly expressed in GALT of therapy-nave HIV-1 infected patients with a progressive clinical course. Heterosexual transmission is the primary mode for the spread of HIV infection and the virus gains entry through mucosal surfaces and infects susceptible target cells. Since a majority of new infections are acquired through the mucosal route, induction of mucosal immunity is an important factor in vaccine design.

UR - http://www.scopus.com/inward/record.url?scp=80053050610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053050610&partnerID=8YFLogxK

U2 - 10.1007/978-1-4020-8412-6_17

DO - 10.1007/978-1-4020-8412-6_17

M3 - Chapter

AN - SCOPUS:80053050610

SN - 9781402084126

SN - 9781402084119

SP - 459

EP - 481

BT - Immunity Against Mucosal Pathogens

PB - Springer Netherlands

ER -